Hongwei Li

Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metas...

Thoracic Radiotherapy Improves the Survival in Patiënten met EGFR-Mutated Oligo-Organ Metastatic Non-Small Cell Lung ...